Evidence map›Paper›PMID 29101242›Full record

ArticleBioscience reports2017

Busulfan administration produces toxic effects on epididymal morphology and inhibits the expression of ZO-1 and vimentin in the mouse epididymis.

Fang Fang, Ke Ni, Yiting Cai, Qian Zhao, Jin Shang, Xiaoke Zhang, Shiliang Shen, Chengliang Xiong

Open access · goldAbstract read
In one paragraph

Article in Bioscience reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. TheCurrent issues in molecular biology · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Fang FangFamily Planning Research Institute, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Ke NiDepartment of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Yiting CaiDepartment of Obstetrics and Gynecology, Center of Reproductive Medicine, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Qian ZhaoFamily Planning Research Institute, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Jin ShangFamily Planning Research Institute, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Xiaoke ZhangFamily Planning Research Institute, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Shiliang ShenDepartment of Pathology, Zhong Shen Bioscience Inc., Wuhan, China.
Chengliang XiongFamily Planning Research Institute, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China clxiong951@sina.com.
Huazhong University of Science and Technology · CNBioscience (China) · CNSecond Affiliated Hospital of Zhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Busulfan is an alkane sulphonate currently used as an anticancer drug and to prepare azoospermic animal models, because it selectively destroys differentiated spermatogonia in the testes. However, few studies have focussed on the exact effects of busulfan treatment on the epididymis currently. The present study assessed the effect of busulfan on epididymal morphology and the blood-epididymis barrier in mice. We treated mice with a single injection of busulfan and detected the effect at different time points. We showed that busulfan was toxic to the morphological structure and function of the epididymis. Furthermore, busulfan treatment down-regulated the epididymal expression of vimentin and zonula occludens-1 (ZO-1) at the mRNA and protein levels. In addition, there was an increase in total androgen receptor (AR) levels, whereas the estrogen receptor-α (ER-α) levels were reduced, both in the caput and cauda regions after busulfan treatment, which may be secondary to the testicular damage. In conclusion, our study describes the effects of busulfan administration on the mouse epididymis and also provides a potential understanding of male infertility arising from chemotherapy-related defects in the epididymis.

Indexed as

AnimalsBusulfanDown-RegulationEpididymisEstrogen Receptor alphaMaleMiceMice, Inbred ICRReceptors, AndrogenTestisVimentinZonula Occludens-1 ProteinBusulfanEstrogen Receptor alphaReceptors, AndrogenTjp1 protein, mouseVimentinZonula Occludens-1 ProteinBlood-epididymis barrierBusulfanEpididymisVimentinZO-1

Identifiers

PMID29101242
PMCPMC5725615
OpenAlexW2766929221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.